Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preserved vs. Reduced Ejection Fraction Biomarker Registry and Precision Medicine Database for Ambulatory Heart Failure Patients (PREFER-HF) Study

NCT03480633 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT03480633
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03480633 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preserved vs. Reduced Ejection Fraction Biomarker Registry and Precision Medicine Database for Ambulatory Heart Failure Patients (PREFER-HF) Study
Lead sponsor
Massachusetts General Hospital
Phase
Observational
Overall status
Recruiting
Start date
April 7, 2016
Completion date
December 31, 2028
Enrollment
3,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular risk factor, heart failure with mid range ejection fraction, heart failure with normal ejection fraction, heart failure with reduced ejection fraction, heart failure, right sided